S090 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sutro Biopharma Inc

Watchlist Manager

Watchlist

Price: 20.2 EUR 1% Market Closed

Market Cap: €172.1m

	Sutro Biopharma Inc F:S090	US
S	Sartorius AG XHAN:SRT	DE
A	Aldeyra Therapeutics Inc XBER:137	US
C	Carrefour SA XHAN:CAR	FR
	Sparta AG F:SPT6	DE
	Vontier Corp F:47O	US
S	Sparta AG XMUN:SPT6	DE
E	Edenred SE F:QSV	FR
S	Southern Financial Corp OTC:SFCO	US
	Hemnet Group AB (publ) STO:HEM	SE
H	Hugo Boss AG XHAN:BOSS	DE
	Aedas Homes SA MAD:AEDAS	ES
	BFI Finance Indonesia Tbk PT IDX:BFIN	ID

Profitability Summary

Sutro Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-87%

Negative 3Y Average Operating Margin

-168%

Operating Margin is Increasing

-279% > -87%

Negative Net Margin

-154%

Negative 3Y Average Net Margin

-194%

Net Margin is Increasing

-251% > -154%

Negative Free Cash Flow Margin

-153%

Negative 3Y Average Free Cash Flow Margin

-180%

Declining Free Cash Flow Margin

-100% > -153%

Exceptional ROE

331%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-242%

Declining ROIC

-147% > -177%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.